4ZZ-20516-84904
2 vaccinations
1 coded response
6 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 850 / AZ
- Registered
- 2021-08-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-07-23
Dose 1 — Pfizer-BioNTech
-
2021-08-13
Registered in v-safe
-
2021-08-13
Dose 2 — Pfizer-BioNTech
- 2021-08-13
-
2021-08-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2021-08-16
- 2021-08-19
- 2021-08-27
-
2022-08-17
Survey response — 12 months, dose 2MedDRA: COVID-19, Cough, Secretion discharge — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Covid positive in January. Cough lasting for more than 6 months. Thicker mucus than usual.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-23 | Pfizer-BioNTech | No |
| 2 | 2021-08-13 | Pfizer-BioNTech | No |
Free text
Release 12 — 12 months, dose 2
Symptoms: Covid positive in January. Cough lasting for more than 6 months. Thicker mucus than usual.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Secretion discharge | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release